9-Nitrominocycline

 化学構造式
149934-16-7
CAS番号.
149934-16-7
化学名:
别名:
英語名:
9-Nitrominocycline
英語别名:
9-Nitro Minocycline;Tigecycline Impurity G;Tigecycline Impurity 12;GEGDTZYTPKKFGB-IRDJJEOVSA-N;TigecyclineImpurity12Hemisulfate;(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino);Minocycline Impurity 5(Minocycline 9-Nitro Impurity);Minocycline EP Impurity G Intermediate(9-Nitro Minocycline);Minocycline Impurity 5 Hemisulfate(Minocycline 9-Nitro Impurity Hemisulfate);Minocycline 9-Nitro ImpurityQ: What is Minocycline 9-Nitro Impurity Q: What is the CAS Number of Minocycline 9-Nitro Impurity
CBNumber:
CB32622575
化学式:
C23H26N4O9
分子量:
502.47
MOL File:
149934-16-7.mol

9-Nitrominocycline 物理性質

沸点 :
825.9±65.0 °C(Predicted)
比重(密度) :
1?+-.0.1 g/cm3(Predicted)
酸解離定数(Pka):
4.50±1.00(Predicted)

安全性情報

9-Nitrominocycline 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

9-Nitrominocycline 化学特性,用途語,生産方法

使用

9-Nitrominocycline is a 9-substituted Minocycline (M344800) derivative used as antibacterial agent.

適応症

Minoxidil, an antihypertensive agent, produces arteriolar vasodilation by an unknown mechanism. In limited clinical studies, minoxidil increases penile rigidity and has been used in the long-term treatment of organic impotence.

生物学の機能

Minoxidil (Loniten) is an orally effective vasodilator. It is more potent and longer acting than hydralazine and does not accumulate significantly in patients with renal insufficiency. It depends on in vivo metabolism by hepatic enzymes to produce an active metabolite, minoxidil sulfate. Minoxidil sulfate activates potassium channels, resulting in hyperpolarization of vascular smooth muscle and relaxation of the blood vessel.

薬理学

The hemodynamic effects of minoxidil are generally similar to those of hydralazine, with the noteworthy exception that a greater decrease in peripheral vascular resistance and consequently a larger reduction in blood pressure can be achieved with minoxidil. Minoxidil produces no important changes in either renal blood flow or glomerular filtration rate. It has little or no effect on venous capacitance and does not inhibit the reflex activation of the sympathetic nervous system. Orthostasis and other side effects of sympathetic blockade are therefore not a problem. As with hydralazine, there is a significant increase in cardiac output that is secondary to reflex increases in sympathetic activity, hyperreninemia, and salt and water retention.These effects can substantially reduce the effectiveness of minoxidil when it is used alone.The addition of a -blocker and a diuretic to the therapeutic regimen will preserve minoxidil’s antihypertensive action while attenuating some of the undesirable side effects.

臨床応用

The major indications for the use of minoxidil are (1) severe hypertension that may be life threatening and (2) hypertension that is resistant to milder forms of therapy. Compromises in renal function do not prolong either the plasma or the therapeutic half-life of minoxidil, and therefore, it seems to be particularly important for hypertensive patients with chronic renal failure.

副作用

Signs of toxicity common to vasodilator therapy in general also occur with minoxidil; they are attributable to vasodilation and reflex increases in sympathetic nerve activity. These include headache, nasal congestion, tachycardia, and palpitations. These effects do not have great clinical importance, since minoxidil is almost always administered in combination with a -blocker, which antagonizes the indirect cardiac effects. A more troublesome side effect, particularly in women, is the growth of body hair, possibly due to a direct stimulation of the growth and maturation of cells that form hair shafts. Apparently, minoxidil activates a specific gene that regulates hair shaft protein. In any case, this particular side effect has been capitalized upon, and minoxidil is now marketed as Rogaine for the treatment of male pattern baldness.

代謝

Peak concentrations of minoxidil in the blood occur 1 hour after oral administration, although the therapeutic effect may take 2 or more hours to manifest. This is probably related to the time it takes to convert minoxidil to minoxidil sulfate. The antihypertensive action after an oral dose of minoxidil lasts 12 to 24 hours. The long duration of action allows the drug to be administered only once or twice a day, a regimen that may be beneficial for compliance. Interestingly, the therapeutic half-life is considerably longer than the plasma half-life. This may be, as has been suggested for hydralazine, a result either of accumulation of the drug and its active metabolite in arterial walls or a longer plasma half-life of the sulfated metabolite, or both.
The ultimate disposition of minoxidil depends primarily on hepatic metabolism and only slightly on renal excretion of unchanged drug. Because of this, pharmacological activity is not cumulative in patients with renal failure.

9-Nitrominocycline 上流と下流の製品情報

原材料

準備製品


9-Nitrominocycline 生産企業

Global( 23)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Guangzhou PI PI Biotech Inc +86-020-81716320 +86-13602409664
Sales@pipitech.com China 3635 55
Chemsky (shanghai) International Co.,Ltd 021-50135380
shchemsky@sina.com China 15421 60
ChemStrong Scientific Co.,Ltd 0755-66853366 13670046396
sales@chem-strong.com China 17982 56
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7851 55
Alchemist-pharm chemical Technology Co. Ltd. 0371-67991738 13783628208
carl@alchemist-pharm.com China 1877 58
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684
sales@rrkchem.com China 55717 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 17825480238
3008233717@qq.com China 9844 12
Hubei Moco Chemical Co., Ltd. 18627756402
3001051413@qq.com China 10009 58

149934-16-7()キーワード:


  • 149934-16-7
  • (4S,4aS,5aR,12aS)-4,7-Bis(diMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxaMide
  • [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(diMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-2-naphthacenecarboxaMide
  • 9-Nitro Minocycline
  • Tigecycline Impurity G
  • (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)
  • Tigecycline Impurity 12
  • GEGDTZYTPKKFGB-IRDJJEOVSA-N
  • Minocycline Impurity 5(Minocycline 9-Nitro Impurity)
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • Minocycline EP Impurity G Intermediate(9-Nitro Minocycline)
  • Minocycline 9-Nitro ImpurityQ: What is Minocycline 9-Nitro Impurity Q: What is the CAS Number of Minocycline 9-Nitro Impurity
  • (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-9-nitro-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • TigecyclineImpurity12Hemisulfate
  • Minocycline Impurity 5 Hemisulfate(Minocycline 9-Nitro Impurity Hemisulfate)
Copyright 2017 © ChemicalBook. All rights reserved